Eton Pharmaceuticals ETON
NASDAQ ETON
$67.54 +3.19 (+4.96%)
At close: Nov 10, 2026 · 4:00 PM EST

Eton Pharmaceuticals (ETON) Long-Term Deferred Tax (2023 - 2026)

Updated

Analysis

Eton Pharmaceuticals (ETON) Long-Term Deferred Tax (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Eton Pharmaceuticals 1.95 Bn 1.82 Bn 44.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.75 Mn
Dec 31, 2024 20.22 Mn
Dec 31, 2023 169,000.00
API Access

Eton Pharmaceuticals Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=ETON&period=max&api_key=YOUR_API_KEY